Deepak Calian Vaidya

Biography

 Strides Shasun Ltd (Strides Shasun) was incorporated in 1990 as Strides Pharmaceuticals Pvt Ltd. In 1996, it was renamed as Strides Acrolab Ltd. In 2015, the company acquired its present name subsequent to its merger with Shasun Pharmaceuticals. The company is a vertically integrated global pharmaceutical company with business footprint across pharmaceuticals, development and manufacturing of APIs and formulations and as well as biotech. Its business divisions are broadly classified as regulated markets, emerging markets, institutional business and pharmaceutical services & active ingredients. The company operates 14 manufacturing facilities, out of which 5 are located in India, 7 in Africa and 2 in Europe. In FY16, regulated markets accounted for 34% of its overall revenues. During the same period, it re-entered the Australian market with the acquisition of generics portfolio from Aspen Pharmacare Holdings Ltd. Further, it entered into an agreement with Sweden based Moberg Pharma, and its affiliates and successfully acquired the brands Jointflex, Fergon and Vanquish.

Research Interest

 Strides Shasun Limited is a Public incorporated on 28 June 1990. It is classified as Non-govt company and is registered at Registrar of Companies, Mumbai. Its authorized share capital is Rs. 1,767,500,030 and its paid up capital is Rs. 893,686,980.It is inolved in Manufacture of other chemical products